|
|
||||||||
1Department of Physiology and Cell Biology and 2Davis Heart and Lung Research Institute, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio 43210
Submitted 9 December 2003 ; accepted in final form 7 April 2004
Mice have been increasingly used as models for investigating cardiovascular diseases. However, the responsiveness of mouse vasculature to endothelin (ET)-1 has not been clearly established. The goal of this study was to determine the role of ET receptors (ETA and ETB) in mouse vessels using isometric force measurements. Results showed that in the abdominal aorta ET-1 induced a concentration-dependent contraction (EC50: 1.4 nM) with maximum reaching 89.5 ± 4.9% (10 nM) of that induced by 60 mM K+ [with nitric oxide synthase (NOS) inhibitor N
-nitro-L-arginine methyl ester (L-NAME)]. However, in the thoracic aorta or the carotid artery, ET-1 was poorly effective. RT-PCR revealed that in the endothelium-denuded abdominal aorta, the PCR product for ETB receptors was very low compared with ETA. Similarly in tissues treated with L-NAME, the ETB receptor-specific agonist sarafotoxin 6c (S6c; 100 nM) induced only a minimal contraction (<5%). Meanwhile, the ETA antagonist BQ-123 (1 µM) completely inhibited the maximum ET-1 (10 nM) contractile response. Furthermore, we found that in the abdominal aorta that had not been treated with L-NAME, ET-1-induced contraction significantly decreased. However, in such specimens, S6c was unable to induce any relaxation on phenylephrine-induced contraction. These results indicate that the role of ET receptors differs considerably among mouse vessels. In the abdominal aorta, ETA receptor mediates a potent vasoconstrictor response, whereas ETB has, if any, only a minimal functional presence. Also, our data suggest that ET-1 might involve a NOS-dependent vasodilation in the abdominal aorta, which remains to be further defined.
endothelinA receptor; endothelinB receptor; vasoconstriction; nitric oxide synthase; vasodilation
This article has been cited by other articles:
![]() |
S. B. Bender and R. E. Klabunde Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and {alpha}1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2281 - H2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, S. Mitra, S. Varadharaj, N. Parinandi, J. L. Zweier, and N. A. Flavahan Increased Expression of Cyclooxygenase-2 Mediates Enhanced Contraction to Endothelin ETA Receptor Stimulation in Endothelial Nitric Oxide Synthase Knockout Mice Circ. Res., June 9, 2006; 98(11): 1439 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Widmer, A. L. Mundy, M. Kretz, and M. Barton Marked heterogeneity of endothelin-mediated contractility and contraction dynamics in mouse renal and femoral arteries. Experimental Biology and Medicine, June 1, 2006; 231(6): 777 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Andresen, N. I. Shafi, and R. M. Bryan Jr. Endothelial influences on cerebrovascular tone J Appl Physiol, January 1, 2006; 100(1): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, S. Varadharaj, X. Zhao, N. Parinandi, N. A. Flavahan, and J. L. Zweier Acetylcholine causes endothelium-dependent contraction of mouse arteries Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1027 - H1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Korzick, J. M. Muller-Delp, P. Dougherty, C. L. Heaps, D. K. Bowles, and K. K. Krick Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: Role of protein kinase C Cardiovasc Res, May 1, 2005; 66(2): 384 - 392. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |